According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Liver Cancer grew percent to account for percent of the total market sales, and Esophageal Cancer grew percent.

PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.

This report studies and analyses global PD-1 and PD-L1 Drug status and future trends, helps the client to determine the PD-1 and PD-L1 Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for PD-1 and PD-L1 Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global PD-1 and PD-L1 Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global PD-1 and PD-L1 Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China PD-1 and PD-L1 Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global PD-1 and PD-L1 Drug key consuming regions, consumption quantity, consumption value and demand structure

(5) Global PD-1 and PD-L1 Drug key producing regions, capacity, production, and year over year growth

(6) PD-1 and PD-L1 Drug industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Bristol Myers Squibb

Merck & Co., Inc.

F. Hoffmann -La Roche Ltd

AstraZeneca

Sanofi

Pfizer Inc

Lilly

Novartis AG

GSK

Junshi Biosciences

Akeso, Inc

BeiGene

Innovent

Jiangsu Hengrui Medicine Co.,Ltd

Cstone

Henlius

Simcere Pharmaceutical Group Limited

Market segment by Type, covers

PD-1 Monoclonal Antibody

PD-L1 Monoclonal Antibody

Market segment by Application, can be divided into

Liver Cancer

Esophageal Cancer

Nasal Cancer

Stomach Cancer

Other

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe PD-1 and PD-L1 Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global PD-1 and PD-L1 Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China PD-1 and PD-L1 Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of PD-1 and PD-L1 Drug, percent & CAGR, 2018-2029

Chapter 5: PD-1 and PD-L1 Drug industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 PD-1 and PD-L1 Drug Definition

1.2 Global PD-1 and PD-L1 Drug Market Size and Forecast

1.2.1 By Consumption Value, Global PD-1 and PD-L1 Drug Market Size，2018-2029

1.2.2 By Sales Quantity, Global PD-1 and PD-L1 Drug Market Size，2018-2029

1.2.3 Global PD-1 and PD-L1 Drug Average Selling Price (ASP)，2018-2029

1.3 China PD-1 and PD-L1 Drug Market Size and Forecast

1.3.1 By Consumption Value, China PD-1 and PD-L1 Drug Market Size，2018-2029

1.3.2 By Sales Quantity, China PD-1 and PD-L1 Drug Market Size，2018-2029

1.3.3 China PD-1 and PD-L1 Drug Average Selling Price (ASP)， 2018-2029

1.4 Share of China PD-1 and PD-L1 Drug Market with Respect to the Global Market

1.4.1 By Consumption Value, China PD-1 and PD-L1 Drug Market Share in Global, 2018-2029

1.4.2 By Sales Quantity, China PD-1 and PD-L1 Drug Market Share in Global, 2018-2029

1.4.3 PD-1 and PD-L1 Drug Market Size: China VS Global, 2018-2029

1.5 PD-1 and PD-L1 Drug Market Dynamics

1.5.1 PD-1 and PD-L1 Drug Market Drivers

1.5.2 PD-1 and PD-L1 Drug Market Restraints

1.5.3 PD-1 and PD-L1 Drug Industry Trends

1.5.4 PD-1 and PD-L1 Drug Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of PD-1 and PD-L1 Drug, Global Market Share by Company, 2018-2023

2.2 By Sales Quantity of PD-1 and PD-L1 Drug, Global Market Share by Company, 2018-2023

2.3 PD-1 and PD-L1 Drug Average Selling Price (ASP) by Company, 2018-2023

2.4 Global PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global PD-1 and PD-L1 Drug Concentration Ratio

2.6 Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans

2.7 Global PD-1 and PD-L1 Drug Manufacturers Product Type

2.8 Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer

2.9 PD-1 and PD-L1 Drug Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of PD-1 and PD-L1 Drug, China Market Share by Company, 2018-2023

3.2 By Sales Quantity of PD-1 and PD-L1 Drug, China Market Share by Company, 2018-2023

3.3 China PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global PD-1 and PD-L1 Drug Capacity, Output and Capacity Utilization, 2018-2029

4.2 Global PD-1 and PD-L1 Drug Capacity by Region

4.3 Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029

4.4 Global PD-1 and PD-L1 Drug Production by Region, 2018-2029

4.5 Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 PD-1 and PD-L1 Drug Industry Chain

5.2 PD-1 and PD-L1 Drug Upstream Analysis

5.2.1 PD-1 and PD-L1 Drug Core Raw Materials

5.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 PD-1 and PD-L1 Drug Production Mode

5.6 PD-1 and PD-L1 Drug Procurement Model

5.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels

5.7.1 PD-1 and PD-L1 Drug Sales Model

5.7.2 PD-1 and PD-L1 Drug Typical Distributors

6 Sights by Type

6.1 PD-1 and PD-L1 Drug Classification

6.1.1 PD-1 Monoclonal Antibody

6.1.2 PD-L1 Monoclonal Antibody

6.2 By Type, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029

6.4 By Type, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029

6.5 By Type, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029

7 Sights by Application

7.1 PD-1 and PD-L1 Drug Segment by Application

7.1.1 Liver Cancer

7.1.2 Esophageal Cancer

7.1.3 Nasal Cancer

7.1.4 Stomach Cancer

7.1.5 Other

7.2 By Application, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029

7.4 By Application, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029

7.5 By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018 VS 2022 VS 2029

8.2 By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029

8.3 By Region, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029

8.4 North America

8.4.1 North America PD-1 and PD-L1 Drug & Forecasts, 2018-2029

8.4.2 By Country, North America PD-1 and PD-L1 Drug Market Size Market Share

8.5 Europe

8.5.1 Europe PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe PD-1 and PD-L1 Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Market Size Market Share

8.7 South America

8.7.1 South America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America PD-1 and PD-L1 Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029

9.2 By Country, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029

9.3 By Country, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029

9.4 U.S.

9.4.1 U.S. PD-1 and PD-L1 Drug Market Size, 2018-2029

9.4.2 By Type, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe PD-1 and PD-L1 Drug Market Size, 2018-2029

9.5.2 By Type, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China PD-1 and PD-L1 Drug Market Size, 2018-2029

9.6.2 By Type, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan PD-1 and PD-L1 Drug Market Size, 2018-2029

9.7.2 By Type, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea PD-1 and PD-L1 Drug Market Size, 2018-2029

9.8.2 By Type, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2018-2029

9.9.2 By Type, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India PD-1 and PD-L1 Drug Market Size, 2018-2029

9.10.2 By Type, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa PD-1 and PD-L1 Drug Market Size, 2018-2029

9.11.2 By Type, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Bristol Myers Squibb

10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position

10.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications, and Application

10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Bristol Myers Squibb Company Profile and Main Business

10.1.5 Bristol Myers Squibb Recent Developments

10.2 Merck & Co., Inc.

10.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position

10.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications, and Application

10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Merck & Co., Inc. Company Profile and Main Business

10.2.5 Merck & Co., Inc. Recent Developments

10.3 F. Hoffmann -La Roche Ltd

10.3.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

10.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application

10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.3.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business

10.3.5 F. Hoffmann -La Roche Ltd Recent Developments

10.4 AstraZeneca

10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position

10.4.2 AstraZeneca PD-1 and PD-L1 Drug Models, Specifications, and Application

10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.4.4 AstraZeneca Company Profile and Main Business

10.4.5 AstraZeneca Recent Developments

10.5 Sanofi

10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position

10.5.2 Sanofi PD-1 and PD-L1 Drug Models, Specifications, and Application

10.5.3 Sanofi PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Sanofi Company Profile and Main Business

10.5.5 Sanofi Recent Developments

10.6 Pfizer Inc

10.6.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position

10.6.2 Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications, and Application

10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Pfizer Inc Company Profile and Main Business

10.6.5 Pfizer Inc Recent Developments

10.7 Lilly

10.7.1 Lilly Company Information, Head Office, Market Area, and Industry Position

10.7.2 Lilly PD-1 and PD-L1 Drug Models, Specifications, and Application

10.7.3 Lilly PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Lilly Company Profile and Main Business

10.7.5 Lilly Recent Developments

10.8 Novartis AG

10.8.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position

10.8.2 Novartis AG PD-1 and PD-L1 Drug Models, Specifications, and Application

10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Novartis AG Company Profile and Main Business

10.8.5 Novartis AG Recent Developments

10.9 GSK

10.9.1 GSK Company Information, Head Office, Market Area, and Industry Position

10.9.2 GSK PD-1 and PD-L1 Drug Models, Specifications, and Application

10.9.3 GSK PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.9.4 GSK Company Profile and Main Business

10.9.5 GSK Recent Developments

10.10 Junshi Biosciences

10.10.1 Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position

10.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications, and Application

10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Junshi Biosciences Company Profile and Main Business

10.10.5 Junshi Biosciences Recent Developments

10.11 Akeso, Inc

10.11.1 Akeso, Inc Company Information, Head Office, Market Area, and Industry Position

10.11.2 Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications, and Application

10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Akeso, Inc Company Profile and Main Business

10.11.5 Akeso, Inc Recent Developments

10.12 BeiGene

10.12.1 BeiGene Company Information, Head Office, Market Area, and Industry Position

10.12.2 BeiGene PD-1 and PD-L1 Drug Models, Specifications, and Application

10.12.3 BeiGene PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.12.4 BeiGene Company Profile and Main Business

10.12.5 BeiGene Recent Developments

10.13 Innovent

10.13.1 Innovent Company Information, Head Office, Market Area, and Industry Position

10.13.2 Innovent PD-1 and PD-L1 Drug Models, Specifications, and Application

10.13.3 Innovent PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Innovent Company Profile and Main Business

10.13.5 Innovent Recent Developments

10.14 Jiangsu Hengrui Medicine Co.,Ltd

10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area, and Industry Position

10.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application

10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business

10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments

10.15 Cstone

10.15.1 Cstone Company Information, Head Office, Market Area, and Industry Position

10.15.2 Cstone PD-1 and PD-L1 Drug Models, Specifications, and Application

10.15.3 Cstone PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Cstone Company Profile and Main Business

10.15.5 Cstone Recent Developments

10.16 Henlius

10.16.1 Henlius Company Information, Head Office, Market Area, and Industry Position

10.16.2 Henlius PD-1 and PD-L1 Drug Models, Specifications, and Application

10.16.3 Henlius PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.16.4 Henlius Company Profile and Main Business

10.16.5 Henlius Recent Developments

10.17 Simcere Pharmaceutical Group Limited

10.17.1 Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area, and Industry Position

10.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications, and Application

10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023

10.17.4 Simcere Pharmaceutical Group Limited Company Profile and Main Business

10.17.5 Simcere Pharmaceutical Group Limited Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. PD-1 and PD-L1 Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. PD-1 and PD-L1 Drug Market Restraints

Table 3. PD-1 and PD-L1 Drug Market Trends

Table 4. PD-1 and PD-L1 Drug Industry Policy

Table 5. Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global PD-1 and PD-L1 Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global PD-1 and PD-L1 Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global PD-1 and PD-L1 Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global PD-1 and PD-L1 Drug Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global PD-1 and PD-L1 Drug Manufacturers Product Type

Table 13. Head Office and PD-1 and PD-L1 Drug Production Site of Key Manufacturer

Table 14. PD-1 and PD-L1 Drug Capacity of Major Manufacturers and Future Plan

Table 15. China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China PD-1 and PD-L1 Drug Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China PD-1 and PD-L1 Drug Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global PD-1 and PD-L1 Drug Production by Region, 2018-2023, (K Units)

Table 20. Global PD-1 and PD-L1 Drug Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)

Table 22. Global PD-1 and PD-L1 Drug Typical Customers

Table 23. PD-1 and PD-L1 Drug Typical Distributors

Table 24. By Type, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global PD-1 and PD-L1 Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029

Table 32. By Country, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029

Table 34. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position

Table 35. Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 36. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Bristol Myers Squibb Company Profile and Main Business

Table 38. Bristol Myers Squibb Recent Developments

Table 39. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position

Table 40. Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 41. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Merck & Co., Inc. Company Profile and Main Business

Table 43. Merck & Co., Inc. Recent Developments

Table 44. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

Table 45. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 46. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. F. Hoffmann -La Roche Ltd Company Profile and Main Business

Table 48. F. Hoffmann -La Roche Ltd Recent Developments

Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 50. AstraZeneca PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 51. AstraZeneca PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. AstraZeneca Company Profile and Main Business

Table 53. AstraZeneca Recent Developments

Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 55. Sanofi PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 56. Sanofi PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Sanofi Company Profile and Main Business

Table 58. Sanofi Recent Developments

Table 59. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position

Table 60. Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 61. Pfizer Inc PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Pfizer Inc Company Profile and Main Business

Table 63. Pfizer Inc Recent Developments

Table 64. Lilly Company Information, Head Office, Market Area, and Industry Position

Table 65. Lilly PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 66. Lilly PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Lilly Company Profile and Main Business

Table 68. Lilly Recent Developments

Table 69. Novartis AG Company Information, Head Office, Market Area, and Industry Position

Table 70. Novartis AG PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 71. Novartis AG PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Novartis AG Company Profile and Main Business

Table 73. Novartis AG Recent Developments

Table 74. GSK Company Information, Head Office, Market Area, and Industry Position

Table 75. GSK PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 76. GSK PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. GSK Company Profile and Main Business

Table 78. GSK Recent Developments

Table 79. Junshi Biosciences Company Information, Head Office, Market Area, and Industry Position

Table 80. Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 81. Junshi Biosciences PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Junshi Biosciences Company Profile and Main Business

Table 83. Junshi Biosciences Recent Developments

Table 84. Akeso, Inc Company Information, Head Office, Market Area, and Industry Position

Table 85. Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 86. Akeso, Inc PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Akeso, Inc Company Profile and Main Business

Table 88. Akeso, Inc Recent Developments

Table 89. BeiGene Company Information, Head Office, Market Area, and Industry Position

Table 90. BeiGene PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 91. BeiGene PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. BeiGene Company Profile and Main Business

Table 93. BeiGene Recent Developments

Table 94. Innovent Company Information, Head Office, Market Area, and Industry Position

Table 95. Innovent PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 96. Innovent PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Innovent Company Profile and Main Business

Table 98. Innovent Recent Developments

Table 99. Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area, and Industry Position

Table 100. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 101. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business

Table 103. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments

Table 104. Cstone Company Information, Head Office, Market Area, and Industry Position

Table 105. Cstone PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 106. Cstone PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Cstone Company Profile and Main Business

Table 108. Cstone Recent Developments

Table 109. Henlius Company Information, Head Office, Market Area, and Industry Position

Table 110. Henlius PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 111. Henlius PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Henlius Company Profile and Main Business

Table 113. Henlius Recent Developments

Table 114. Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area, and Industry Position

Table 115. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications, and Application

Table 116. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. Simcere Pharmaceutical Group Limited Company Profile and Main Business

Table 118. Simcere Pharmaceutical Group Limited Recent Developments

List of Figures

Figure 1. PD-1 and PD-L1 Drug Picture

Figure 2. Global PD-1 and PD-L1 Drug Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global PD-1 and PD-L1 Drug Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global PD-1 and PD-L1 Drug Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China PD-1 and PD-L1 Drug Consumption Value, (US$ million) & (2018-2029)

Figure 6. China PD-1 and PD-L1 Drug Sales Quantity (K Units) & (2018-2029)

Figure 7. China PD-1 and PD-L1 Drug Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China PD-1 and PD-L1 Drug Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China PD-1 and PD-L1 Drug Market Share of Global, 2018-2029

Figure 10. Global PD-1 and PD-L1 Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2022

Figure 12. Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global PD-1 and PD-L1 Drug Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029

Figure 15. PD-1 and PD-L1 Drug Industry Chain

Figure 16. PD-1 and PD-L1 Drug Procurement Model

Figure 17. PD-1 and PD-L1 Drug Sales Model

Figure 18. PD-1 and PD-L1 Drug Sales Channels, Direct Sales, and Distribution

Figure 19. PD-1 Monoclonal Antibody

Figure 20. PD-L1 Monoclonal Antibody

Figure 21. By Type, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million

Figure 22. By Type, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029

Figure 23. By Type, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 24. By Type, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029

Figure 25. By Type, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 26. Liver Cancer

Figure 27. Esophageal Cancer

Figure 28. Nasal Cancer

Figure 29. Stomach Cancer

Figure 30. Other

Figure 31. By Application, Global PD-1 and PD-L1 Drug Consumption Value, 2018-2029, US$ Million

Figure 32. By Application, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029

Figure 33. By Application, Global PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 34. By Application, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029

Figure 35. By Application, Global PD-1 and PD-L1 Drug Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 36. By Region, Global PD-1 and PD-L1 Drug Consumption Value Market Share, 2018-2029

Figure 37. By Region, Global PD-1 and PD-L1 Drug Sales Quantity Market Share, 2018-2029

Figure 38. North America PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 39. By Country, North America PD-1 and PD-L1 Drug Consumption Value Market Share, 2022

Figure 40. Europe PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, Europe PD-1 and PD-L1 Drug Consumption Value Market Share, 2022

Figure 42. Asia Pacific PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 43. By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Consumption Value Market Share, 2022

Figure 44. South America PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, South America PD-1 and PD-L1 Drug Consumption Value Market Share, 2022

Figure 46. Middle East & Africa PD-1 and PD-L1 Drug Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 47. U.S. PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, U.S. PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 50. Europe PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, Europe PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 53. China PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, China PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 56. Japan PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, Japan PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 59. South Korea PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, South Korea PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 62. Southeast Asia PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, Southeast Asia PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 65. India PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, India PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 68. Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity, 2018-2029, (K Units)

Figure 69. By Type, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, Middle East & Africa PD-1 and PD-L1 Drug Sales Quantity Market Share, 2022 VS 2029

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches